NCT00529438View on ClinicalTrials.gov

RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 1, 2008

Study Completion Date

December 1, 2008

Conditions
Advanced Solid TumorsLymphoid Malignancies
Interventions
DRUG

Bardoxolone methyl

Trial Locations (3)

44106

Case Western Reserve University, Cleveland

77030

MD Anderson Cancer Center, Houston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00529438 - RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies | Biotech Hunter | Biotech Hunter